Fabien Lecaille

3.6k total citations
76 papers, 2.9k citations indexed

About

Fabien Lecaille is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Fabien Lecaille has authored 76 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cancer Research, 34 papers in Molecular Biology and 17 papers in Oncology. Recurrent topics in Fabien Lecaille's work include Protease and Inhibitor Mechanisms (40 papers), Peptidase Inhibition and Analysis (11 papers) and Cell Adhesion Molecules Research (9 papers). Fabien Lecaille is often cited by papers focused on Protease and Inhibitor Mechanisms (40 papers), Peptidase Inhibition and Analysis (11 papers) and Cell Adhesion Molecules Research (9 papers). Fabien Lecaille collaborates with scholars based in France, Canada and United States. Fabien Lecaille's co-authors include Dieter Brömme, Gilles Lalmanach, J. Kaleta, Ahlame Saidi, Charles S. Craik, Youngchool Choe, Jonathan A. Ellman, Doron C. Greenbaum, Francesco Leonetti and Matthew Bogyo and has published in prestigious journals such as Chemical Reviews, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Fabien Lecaille

73 papers receiving 2.9k citations

Peers

Countries citing papers authored by Fabien Lecaille

Since Specialization

Citations

This map shows the geographic impact of Fabien Lecaille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabien Lecaille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabien Lecaille more than expected).

Fields of papers citing papers by Fabien Lecaille

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabien Lecaille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabien Lecaille. The network helps show where Fabien Lecaille may publish in the future.

Co-authorship network of co-authors of Fabien Lecaille

This figure shows the co-authorship network connecting the top 25 collaborators of Fabien Lecaille. A scholar is included among the top collaborators of Fabien Lecaille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabien Lecaille. Fabien Lecaille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chondroitin 4-Sulfate Disaccharide-Based Inhibitors of Cathepsin S 2025 ·Polysaccharides ·(unknown), (unknown), (unknown), (unknown), (unknown), Martyna Maszota‐Zieleniak, Ludovic Landemarre, Marie Schuler, Gilles Lalmanach, Sergey A. Samsonov, Chrystel Lopin‐Bon, Fabien Lecaille	0
2	Exposure to cigarette smoke triggers proteolytic cleavage of occludin, a tight junction protein, by cathepsin S and impairs the pulmonary epithelial barrier during COPD 2023 ·Revue des Maladies Respiratoires ·(unknown), (unknown), Ahlame Saidi, (unknown), (unknown), Yves Courty, Fabien Lecaille, Gilles Lalmanach	0
3	The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis 2023 ·Biomedicines ·(unknown), (unknown), Ahlame Saidi, Gilles Lalmanach, Fabien Lecaille	6
4	In silico and in vitro mapping of specificity patterns of glycosaminoglycans towards cysteine cathepsins B, L, K, S and V 2022 ·Journal of Molecular Graphics and Modelling ·(unknown), (unknown), Gilles Lalmanach, Fabien Lecaille, Sergey A. Samsonov	10
5	Upregulation of gut cathepsin L during Eimeria tenella infection 2021 ·Research in Veterinary Science ·Ahlame Saidi, Pauline Gaboriaud, Anne-Christine Lalmanach, (unknown), (unknown), (unknown), (unknown), Rodrigo Guabiraba, Catherine Schouler, Fabrice Laurent, Édouard Guitton, Fabien Lecaille, Françoise I. Bussière, Gilles Lalmanach	3
6	Oxidation of cathepsin S by major chemicals of cigarette smoke 2020 ·Free Radical Biology and Medicine ·(unknown), (unknown), Ahlame Saidi, (unknown), Lydie Nadal‐Desbarats, Fabien Lecaille, Gilles Lalmanach	15
7	Imaging of extracellular cathepsin S activity by a selective near infrared fluorescence substrate-based probe 2019 ·Biochimie ·(unknown), Ahlame Saidi, Mathieu Galibert, (unknown), Julien Burlaud‐Gaillard, Fabien Lecaille, Christopher J. Scott, Vincent Aucagne, (unknown), Gilles Lalmanach	11
8	Selective inhibition of human cathepsin S by 2,4,6-trisubstituted 1,3,5-triazine analogs 2018 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), (unknown), Vincent Roy, Fabien Lecaille, Dawid Warszycki, Andrzej J. Bojarski, Gilles Lalmanach, Luigi A. Agrofoglio	11
9	Active site labeling of cysteine cathepsins by a straightforward diazomethylketone probe derived from the N-terminus of human cystatin C 2015 ·Biochemical and Biophysical Research Communications ·(unknown), Ahlame Saidi, Brendan Gilmore, (unknown), Vincent Roy, Luigi A. Agrofoglio, (unknown), Fabien Lecaille, Gilles Lalmanach	7
10	Antimicrobial proteins and peptides in human lung diseases: A friend and foe partnership with host proteases 2015 ·Biochimie ·Fabien Lecaille, Gilles Lalmanach, (unknown)	53
11	Human Cysteine Cathepsins Are Not Reliable Markers of Infection by Pseudomonas aeruginosa in Cystic Fibrosis 2011 ·PLoS ONE ·Clément Naudin, (unknown), G. Couetdic, Patrick Plésiat, Aneta Szymańska, (unknown), Francis Gauthier, Franciszek Kasprzykowski, Fabien Lecaille, Gilles Lalmanach	23
12	The Occluding Loop of Cathepsin B Prevents Its Effective Inhibition by Human Kininogens 2010 ·Journal of Molecular Biology ·Clément Naudin, Fabien Lecaille, S. Chowdhury, Joanne C. Krupa, Enrico O. Purisima, John S. Mort, Gilles Lalmanach	13
13	Extracellular catalase activity protects cysteine cathepsins from inactivation by hydrogen peroxide 2008 ·FEBS Letters ·Virginie Hervé‐Grépinet, Florian Veillard, Emmanuel Godat, Nathalie Heuzé‐Vourc'h, Fabien Lecaille, Gilles Lalmanach	20
14	Biochemical properties and regulation of cathepsin K activity 2007 ·Biochimie ·Fabien Lecaille, Dieter Brömme, Gilles Lalmanach	145
15	Cysteine cathepsins and caspases in silicosis 2006 ·Biological Chemistry ·Gilles Lalmanach, Élisabeth Diot, Emmanuel Godat, Fabien Lecaille, Virginie Hervé‐Grépinet	31
16	Substrate Profiling of Cysteine Proteases Using a Combinatorial Peptide Library Identifies Functionally Unique Specificities 2006 ·Journal of Biological Chemistry ·Youngchool Choe, Francesco Leonetti, Doron C. Greenbaum, Fabien Lecaille, Matthew Bogyo, Dieter Brömme, Jonathan A. Ellman, Charles S. Craik	344
17	Congopain from Trypanosoma congolense: Drug Target and Vaccine Candidate 2002 ·Biological Chemistry ·Gilles Lalmanach, Alain Boulangé, Carole Serveau, Fabien Lecaille, Júlio Scharfstein, Francis Gauthier, Édith Authié	58
18	Subsite specificity of trypanosomal cathepsin L‐like cysteine proteases 2001 ·European Journal of Biochemistry ·Fabien Lecaille, Édith Authié, Thierry Moreau, Carole Serveau, Francis Gauthier, Gilles Lalmanach	32
19	Revisiting the S2 specificity of papain by structural analogs of Phe 1999 ·FEBS Letters ·Fabien Lecaille, Carole Serveau, Francis Gauthier, Gilles Lalmanach	14
20	Inhibition of Trypanosomal Cysteine Proteinases by Their Propeptides 1998 ·Journal of Biological Chemistry ·Gilles Lalmanach, Fabien Lecaille, Jair R. Chagas, Édith Authié, Júlio Scharfstein, María A. Juliano, Francis Gauthier	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact